Medical devices and health technologies
PATH's medical devices and health technologies program leads the vanguard in translating innovative ideas into breakthrough health solutions. We accelerate access to affordable, appropriate health solutions to protect and treat the communities that need them most.
Contact
- Tel: 206.285.3500
- innovation@path.org
What we do
Advancing critical health technologies
All too often, existing medical devices and health technologies are inaccessible because they are too expensive or impractical for use in under-resourced health settings. We respond to these challenges by developing and scaling devices and tools with the potential to address the diseases and health issues that disproportionately affect women and children in low-resource settings.
What we do
Our global health impact
Together with our public- and private-sector partners, the Medical Devices and Health Technologies program has investigated hundreds of medical devices, health technologies, and tools and advanced the most promising and appropriate technologies into affordable commercial products for use in country health programs and global health campaigns, reaching billions of people.
We advance medical devices and health technologies that address the primary causes of maternal, newborn, and child mortality and morbidity, and maximize public health impact by increasing availability and access to these innovations as part of integrated health systems.
We optimize, adapt, test, and validate emerging concepts, technologies, and product formats that optimize vaccine and pharmaceutical efficacy, stability, safety, and ease of use. We develop and qualify analytical assays to support development of stable vaccine and pharmaceutical products. Some examples include oral liquid formulations and sublingual and fast-dissolving tablets.
We identify and advance primary packaging and delivery innovations for vaccines and pharmaceuticals that have the potential to maximize efficacy, increase access, and reduce costs. This improves the safety, acceptability, and effectiveness of immunization and drug delivery.
We advance supply systems and equipment, policies, and programs to help to store, monitor, and transport vaccines at appropriate temperatures across the supply chain. This work builds stronger immunization supply and logistics systems to reach every child.
-
January 12, 2024Microarray patch resources
-
Innovations by the numbers
-
December 21, 2023Reinventing the Past to Reshape the Future of Contraception: The Story of the SILCS Diaphragm
-
December 21, 2023Devices, Diagnostics, and Drugs to Address Women’s Needs (D3AWN) Product Development Partnership (PDP) Case Studies and Impact Stories
-
December 21, 2023PATHOS: A human centered design toolkit for engaging frontline health care providers
-
May 24, 2024Total cost of ownership tool for cold chain equipment
Meet the team
-
Courtney Jarrahian
Global Program Leader
-
Emily Jeffers
Director of Finance and Administration
-
Dr. Manjari Lal
Portfolio Leader: Formulation Technologies
-
Dr. Patricia Coffey
Portfolio Leader: Health Technologies for Women and Children
-
Joanie Robertson
Portfolio Leader: Supply Systems and Equipment
-
Jessica Mistilis
Portfolio Leader: Packaging and Delivery Technologies
-
Steven Diesburg
Product Development Engineering Lead
-
Dr. Mercy Mvundura
Technical Advisor Health Economics
-
Rachel Hammack
Communications Manager
-
Brian Taliesin
Global Director, Living Labs, Center of Digital and Data Excellence
-
Dr. Jessica White
Evaluation and Research Laboratory Lead
-
Betsy Wilskie
Procurement and Supply Technical Assistance Lead